Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Christopher S
Adverse reactions observed during Week 26 to 52 of the Phase 3 clinical trials which had an incidence of 1% and were seen more frequently with tesamorelin relative to placebo are presented in Table 2: For patients who continued from Week 26-52, mean levels of fasting blood glucose, fasting insulin, and HbA1c were not different between the T-T and T-P groups
Dosing adjusted to your response
We recommend eating smaller meals throughout the day at designated times
US$ 26.84
US$ 25.85
US$ 27.77
US$ 25.01
US$ 20.61
US$ 26.16
US$ 28.38
